Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 37Melanosis 3Carcinoma, Basal Cell 3Warts 2Keratosis, Seborrheic 1Keratosis 1Facies 1Condylomata Acuminata 1Carcinoma, Squamous Cell 1Carcinoma 1Bowen's Disease 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Vaccines, Synthetic 10Papillomavirus Vaccines 6Vaccines 5Imiquimod 4Trichloroacetic Acid 3Gels 3green tea extract polyphenone E 2Podophyllin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2Duration of Therapy 2Cryotherapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1hecolin 1berdazimer sodium 1Zinc 1Viusid 1Vaccination 1VP-102 1Tuberculin 1Therapies, Investigational 1Tea 1PRA1 protein, Candida albicans 1Omiganan 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Condylomata Acuminata × 3-ingenyl angelate × Clear all
NCT02377999 2025-02-24

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

LEO Pharma

Phase 2 Completed
40 enrolled

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡